Secretome Therapeutics
PrivateLast Round
Series A
May 27, 2026
Total Funding Raised
$31.75M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Secretome Therapeutics is a clinical-stage biotechnology company developing novel therapies derived from neonatal cardiac progenitor cells to address cardiovascular diseases and inflammatory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Secretome Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Secretome Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 27, 2026 | ||||
| Grant | Mar 24, 2026 | ||||
| VC Round | Nov 25, 2024 | ||||
| Seed | Oct 17, 2019 |
Secretome Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HEST Investments | VC Round |
| RA Capital Management | Series A |
| Parent Project Muscular Dystrophy | Grant |
| Abell Foundation | Seed |
| TEDCO | Seed |
| UM Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
$30M round led by RA Capital Management
- May 22, 2026
Grew 21% QoQ from 14 to 17 employees.
Secretome Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Secretome Therapeutics's valuation, stock price, and market status.